QQ客服 官方微博 反馈留言

浏览/检索结果: 共12条，第1-10条 帮助 限定条件 发表日期：2019    内容类型：会议论文     已选(0)清除 条数/页：5101520253035404550556065707580859095100   排序方式：请选择作者升序作者降序题名升序题名降序发表日期升序发表日期降序提交时间升序提交时间降序 Visceral metastases should distinguish between liver or lung when treating HR-positive/HER2-negative advanced breast cancer with fulvestrant 会议论文 作者:  He, M.;  Li, J. -J.;  Zuo, W. -J.;  Wang, Z. -H.;  Shao, Z. -M. 收藏  |  浏览/下载：1/0  |  提交时间：2019/12/05 Advanced non-small cell lung cancer patients with low tumor mutation burden might derive benefit from anti-programmed cell death (PD)-1 and anti-programmed deathligand 1 (PD-L1) blockade 会议论文 作者:  Nie, W.;  Xu, M-D.;  Gan, L.;  Zhang, Y.;  Han, B-H. 收藏  |  浏览/下载：9/0  |  提交时间：2019/12/05 Risk Factors for Developing T790M Mutation in Patients with EGFR-Mutated Advanced Non-Small Cell Lung Cancer 会议论文 作者:  Ouyang, W.;  Xie, C. 收藏  |  浏览/下载：9/0  |  提交时间：2019/12/05 Risk Factors for Developing T790M Mutation in Patients with EGFR-Mutated Advanced Non-Small Cell Lung Cancer 会议论文 作者:  Ouyang, W.;  Xie, C. 收藏  |  浏览/下载：7/0  |  提交时间：2019/12/05 Multiple Chemotherapy-Based Combination Therapy Strategies for Advanced Lung Cancer Patients: A Systematic Review and Network Meta-Analysis 会议论文 作者:  Xiong, L.;  Bai, Y.;  Zhao, J.;  Lanuti, M.;  Tang, H. 收藏  |  浏览/下载：5/0  |  提交时间：2019/12/05 combination therapy  Advanced lung cancer  network meta-analysis   RATIONALE 001: Tislelizumab (BGB-A317) 1 concurrent chemoradiotherapy (cCRT) followed by tislelizumab monotherapy in patients (pts) with newly diagnosed locally advanced, unresectable, stage III non-small cell lung cancer (NSCLC) 会议论文 ANNALS OF ONCOLOGY, 2019-04-01 作者:  Paz-Ares, L.;  Senan, S.;  Planchard, D.;  Wang, L.;  Cheong, A. 收藏  |  浏览/下载：4/0  |  提交时间：2020/01/03 Prognostic interaction of smoking history with circulating regulatory T cells in advanced non-small cell lung cancer. 会议论文 Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), MAY 31-JUN 04, 2019 作者:  Liu, Chao;  Sun, Yi;  Yue, Jinbo;  Yu, Jinming 收藏  |  浏览/下载：5/0  |  提交时间：2019/12/31 Primary results from TAIL, a global single-arm safety study of atezolizumab (atezo) monotherapy in a diverse population of patients with previously treated advanced non-small cell lung cancer (NSCLC) 会议论文 44th Congress of the European-Society-for-Medical-Oncology (ESMO), SEP 27-OCT 01, 2019 作者:  Ardizzoni, A.;  Azevedo, S.;  Rubio Viquiera, B.;  Rodriguez Abreu, D.;  Alatorre-Alexander, J. 收藏  |  浏览/下载：16/0  |  提交时间：2019/12/31 A Multi-Center Randomized Trial Using Compound Kushen Injection to Decrease Chemoradiotherapy Induced Thoracic Toxicities in Patients with Locally Advanced Non-Small Cell Lung Cancer 会议论文 61st Annual Meeting of the American-Society-for-Radiation-Oncology (ASTRO), SEP 15-18, 2019 作者:  Yu, Q.;  Yuan, S.;  Wang, J. 收藏  |  浏览/下载：7/0  |  提交时间：2019/12/31 Dynamic Monitoring of Response Heterogeneity between Primary and Metastases Reveals Resistance Molecular Mechanisms in Advanced Non-Small Cell Lung Cancer with Acquired Resistance to EGFR-TKIs. 会议论文 61st Annual Meeting of the American-Society-for-Radiation-Oncology (ASTRO), SEP 15-18, 2019 作者:  Dong, X.;  Xing, L.;  Sun, X.;  Wan, H.;  Yu, J. 收藏  |  浏览/下载：5/0  |  提交时间：2019/12/31